全文获取类型
收费全文 | 6669篇 |
免费 | 854篇 |
国内免费 | 167篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 51篇 |
妇产科学 | 47篇 |
基础医学 | 208篇 |
口腔科学 | 151篇 |
临床医学 | 1253篇 |
内科学 | 289篇 |
皮肤病学 | 25篇 |
神经病学 | 129篇 |
特种医学 | 45篇 |
外科学 | 275篇 |
综合类 | 857篇 |
一般理论 | 1篇 |
预防医学 | 668篇 |
眼科学 | 29篇 |
药学 | 3255篇 |
31篇 | |
中国医学 | 310篇 |
肿瘤学 | 54篇 |
出版年
2024年 | 18篇 |
2023年 | 202篇 |
2022年 | 245篇 |
2021年 | 390篇 |
2020年 | 458篇 |
2019年 | 270篇 |
2018年 | 253篇 |
2017年 | 269篇 |
2016年 | 261篇 |
2015年 | 318篇 |
2014年 | 586篇 |
2013年 | 648篇 |
2012年 | 476篇 |
2011年 | 472篇 |
2010年 | 396篇 |
2009年 | 357篇 |
2008年 | 353篇 |
2007年 | 331篇 |
2006年 | 260篇 |
2005年 | 205篇 |
2004年 | 205篇 |
2003年 | 171篇 |
2002年 | 141篇 |
2001年 | 84篇 |
2000年 | 67篇 |
1999年 | 80篇 |
1998年 | 55篇 |
1997年 | 36篇 |
1996年 | 24篇 |
1995年 | 11篇 |
1994年 | 8篇 |
1993年 | 11篇 |
1992年 | 6篇 |
1991年 | 14篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1986年 | 3篇 |
1983年 | 1篇 |
1977年 | 1篇 |
排序方式: 共有7690条查询结果,搜索用时 15 毫秒
21.
目的 通过循证医学方法研究肾上腺皮质激素在川崎病治疗中的作用.方法 采用循证医学方法,检索国内外5种大型专业数据库,筛选出随机或半随机对照研究的文献,再人工筛查确定适宜文献.通过Meta分析,比较激素与丙种球蛋白治疗川崎病在退热时间和冠状动脉病变发生率方面的差异.结果 初筛得到443篇文献.经过人工检索,8篇文献符合要求而被纳入标准.其中,3篇文献共有49例川崎病患儿接受甲基强的松龙治疗,5篇文献共有406例患儿接受强的松治疗.对照组共有33例接受静脉丙种球蛋白治疗,435例接受阿司匹林治疗.各组间患儿性别、年龄、病程差异无显著意义.①甲基强的松龙组(3篇文献):24例发生冠状动脉病变,对照组18例发生,两组病变发生率差异无显著意义.在退热方面,1篇文献显示甲基强的松龙组发热时间明显较丙种球蛋白组缩短,差异有显著意义;2篇文献显示差异无显著意义.②强的松组(8篇文献):28例发生冠状动脉瘤,阿司匹林对照组11例发生,3篇文献提示强的松组冠状动脉瘤发生率明显高于对照组.强的松组76例发生冠状动脉扩张,对照组75例发生,3篇文献提示强的松组冠状动脉扩张发生率明显高于对照组,2篇文献提示强的松组冠状动脉扩张发生率略低于对照组,但差异无显著意义.结论 目前的研究资料显示,激素治疗与丙种球蛋白治疗川崎病在冠状动脉病变发生率方面尚无差异或增高.在缩短热程上两者差异也不显著.尚可进一步通过更大数量病例的随机对照研究来证实本结果.目前治疗川崎病不主张单独应用激素. 相似文献
22.
Albert J Finestone Michael R Jacobs John A Cacciamani 《Clinical Interventions in Aging》2007,2(4):715-718
Critical to survival is the geriatric concept, allostasis, defined as the ability to achieve stability through change. It is appropriate that allostasis is an introduction to this commentary, which may partially apply to the medical and pharmacy profession as currently constituted. 相似文献
23.
EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force 总被引:2,自引:0,他引:2
R. Soffietti P. Cornu J. Y. Delattre R. Grant F. Graus W. Grisold J. Heimans J. Hildebrand P. Hoskin M. Kalljo P. Krauseneck C. Marosi T. Siegal C. Vecht 《European journal of neurology》2006,13(7):674-681
The objectives have been to establish evidence-based guidelines and identify controversies regarding the management of patients with brain metastases. The collection of scientific data was obtained by consulting the Cochrane Library, bibliographic databases, overview papers and previous guidelines from scientific societies and organizations. A tissue diagnosis is necessary when the primary tumor is unknown or the aspect on computed tomography/magnetic resonance imaging is atypical. Dexamethasone is the corticosteroid of choice for cerebral edema. Anticonvulsants should not be prescribed prophylactically. Surgery should be considered in patients with up to three brain metastases, being effective in prolonging survival when the systemic disease is absent/controlled and the performance status is high. Stereotactic radiosurgery should be considered in patients with metastases of 3–3.5 cm of maximum diameter. Whole-brain radiotherapy (WBRT) after surgery or radiosurgery is debated: in case of absent/controlled systemic cancer and Karnofsky Performance score of 70 or more, one can either withhold initial WBRT or deliver early WBRT with conventional fractionation to avoid late neurotoxicity. WBRT alone is the treatment of choice for patients with single or multiple brain metastases not amenable to surgery or radiosurgery. Chemotherapy may be the initial treatment for patients with brain metastases from chemosensitive tumors. 相似文献
24.
25.
循证医学决策模式的建立与应用 总被引:1,自引:1,他引:0
循证医学决策模式是建立在对客观的医学研究证据,长期的临床工作经验,及不同患的医疗需求进行综合分析基础上的最佳医疗方案。其建立和应用对提高医疗质量,改善医疗服务质量具有重要意义。树立循证医学决策意识,建立循证医学决策系统,实施循证医学决策管理将为军队医疗系统实现全面品质管理提供可靠依据。 相似文献
26.
We describe how adverse drug reactions (ADRs) can play an important role in pharmaceutical research and drug development. Not only do ADRs represent the risks and drawbacks associated with drugs but they can also be related to other knowledge available in pharmaceutical and medical research. We offer a model that can be used to systematically map the pathways through which ADRs can lead to innovative research. These pathways include chemical, therapeutic or pathophysiological steps that can be taken to arrive at new knowledge based on ADRs. We used the development of angiotensin-converting enzyme inhibitors, especially captopril, as a case study. The similarity between the ADR profiles of captopril and penicillamine was a starting point for further innovation. Historical analysis shows that in several instances research in the field of angiotensin-converting enzyme inhibitors has been triggered by ADRs. The model presented here might be applicable to other areas of innovative drug research. 相似文献
27.
Stroke rehabilitation is an area of practice that many occupational therapists encounter during their career. The literature promotes a wide range of management techniques and support devices for people who have a stroke-affected upper limb, but little is known about the validity of those that occupational therapists actually use in practice. A questionnaire was sent to occupational therapists working in Queensland and northern New South Wales facilities (n = 35), in which adults with a stroke were likely to be treated. Eighteen respondents answered questions about the management techniques and support devices used in their facility, and their perception of the benefit of these devices in the reduction of hemiplegic shoulder pain. Results are discussed with reference to evidence-based practice and indicate an urgent need for the collation and dissemination of the best current evidence available for the management techniques and support devices used in this area, as well as further research to extend this evidence. 相似文献
28.
急性缺血十牛卒中的抗凝治疗存在着很大的争议。本文综述了常用抗凝药物如肝素、低分子肝素的作川机制,并从循证医学角度对近年来发表的一些关于急性缺血性卒中抗凝治疗的大型临床试验进行了总结。 相似文献
29.
30.
沈慧凤 《中国新药与临床杂志》1994,(6)
药用新辅料是药物制剂的基础材料和重要组成部分,在制剂剂型的发展和生产中起着关键作用。它不仅赋予药物一定的剂型,并且与提高药物的疗效、降低毒副作用有很大的关系。因此,研究开发、合理应用新辅料不仅是提高我国药物制剂质量和生产技术水平的重要方向,而且可取得较大的社会及经济效益。 相似文献